Athyrium Capital Management, LP

Type

Venture Capital

Status

Active

Location

New York, United States

Total investments

42

Average round size

126M

Portfolio companies

33

Rounds per year

2.62

Lead investments

5

Follow on index

0.21

Exits

25

Stages of investment
Private Equity
Areas of investment
BiotechnologySoftwareHealth CareHospitalManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsClinical Trials

Summary

In 2008 was created Athyrium Capital Management, LP, which is appeared as VC. The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.

The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2014. Comparing to the other companies, this Athyrium Capital Management, LP performs on 10 percentage points more the average number of lead investments. The real fund results show that this VC is 36 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of more than 100 millions dollars.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Diagnostics, E-Commerce. Among the various public portfolio startups of the fund, we may underline Clover Health, VillageMD, TRIA Beauty Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Athyrium Capital Management, LP, startups are often financed by Oxford Finance LLC, Avista Capital Partners, WFD Ventures. The meaningful sponsors for the fund in investment in the same round are First Round Capital, Wildcat Venture Partners, Vivo Capital. In the next rounds fund is usually obtained by Greenoaks Capital, Wildcat Venture Partners, Sequoia Capital.

This organization was formed by Jeffrey A Ferrell. The overall number of key employees were 8.

Show more

Investor highlights

Industry focus
HealthcareBiotech/Life SciencesMedtechManufacturing
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
42
Lead investments
5
Exits
25
Rounds per year
2.62
Follow on index
0.21
Investments by industry
  • Biotechnology (27)
  • Health Care (22)
  • Medical (19)
  • Pharmaceutical (17)
  • Software (5)
  • Show 27 more
Investments by region
  • United States (31)
  • Denmark (2)
  • Sweden (1)
  • Norway (1)
  • Switzerland (1)
  • Show 4 more
Peak activity year
2018
Number of Unicorns
3
Number of Decacorns
3
Number of Minotaurs
5

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
153M
Group Appearance index
0.33
Avg. company exit year
14
Avg. multiplicator
0.84
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Vytyl Health Management 09 Jan 2024 Health Care, Wellness, Personal Health Early Stage Venture 22M United States, Connecticut, New Haven

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.